Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03477513 : Personalized Treatment of Glioblastoma Via Image-Guided Predictive Modeling of Recurrence: A Single-Arm, Single Institutional Pilot Prospective Study of Dose-Escalated Radiation Therapy
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Patients with biopsy-proven WHO Grade IV glioblastoma, after gross-total or near-total
resection, who are undergoing definitive chemoradiation as part of their treatment

- Age 18 or older

- Ability to give signed informed consent

- Karnofsky Performance Status (KPS) at least 70

Exclusion Criteria:

- Placement of Gliadel wafers

- Participation in another investigational trial

- Active treatment of another malignancy
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557